Phio Pharmaceuticals Corp. (NASDAQ: PHIO) Stock Information | RedChip

Phio Pharmaceuticals Corp. (NASDAQ: PHIO) Listen to this Section


$2.99
+0.4100 ( +15.89% ) 42.9K

Phio Pharmaceuticals Corp is a clinical-stage biotechnology company whose proprietary INTASYL self-delivering RNAi technology platform is designed to make immune cells more effective in killing tumor cells. The Company is developing therapeutics that are designed to leverage INTASYL to precisely target specific proteins that reduce the body's ability to fight cancer, without the need for specialized formulations or drug delivery systems.

Market Data


Open


$2.99

Previous close


$2.58

Volume


42.9K

Market cap


$1.52M

Day range


$2.55 - $3.06

52 week range


$2.40 - $29.07

Insider Ownership Transactions

Total Amount Purchased: 786.00 | $ 2,350.14

Date Type Amount Purchased Purchaser
2024-06-11 Buy 1000.00 Bitterman Robert J
2024-06-10 Buy 1000.00 Bitterman Robert J
2024-03-05 Sale -335.00 Kontulis Caitlin
2024-02-27 Buy 2500.00 Bitterman Robert J
2024-02-22 Sale -1804.00 Bitterman Robert J
2024-02-20 Sale -658.00 Kontulis Caitlin
2023-10-03 Sale -917.00 Bitterman Robert J

SEC Fillings


Form Type Description Pages Date
4 Insider transactions 1 Aug 15, 2024
8-k 8K-related 15 Aug 14, 2024
10-q Quarterly Reports 54 Aug 14, 2024
3 Insider transactions 1 Aug 09, 2024
8-k 8K-related 16 Aug 01, 2024
8-k 8K-related 13 Jul 24, 2024
8-k 8K-related 18 Jul 12, 2024
8-k 8K-related 15 Jul 05, 2024
8-k 8K-related 16 Jul 02, 2024
8-k 8K-related 14 Jun 21, 2024

Latest News


Terms and Agreement

Please agree to the terms to continue using the chat feature.